![]() |
|
|
Vol. 301, Issue 1, 306-314, April 2002
2-Receptor Regulation of Dopamine Transporter via
Activation of Protein Kinase C
Department of Pharmacology, The George Washington University
Medical Center, Washington, DC
The elucidation of the mechanisms underlying
2-receptor activation and signal transduction is crucial
to the understanding of
2-receptor function.
Previous studies in our laboratory have demonstrated
2-receptor-mediated regulation of the dopamine
transporter (DAT) as measured by amphetamine-stimulated release of
[3H]dopamine (DA) from both rat striatal slices and PC12
cells. The regulation of the DAT in the PC12 cell model was dependent upon activation of Ca2+/calmodulin-dependent kinase II. We
have now studied the second messenger systems involved in
2-receptor-mediated regulation of amphetamine-stimulated
[3H]DA release in rat striatal slices, including
Ca2+/calmodulin-dependent kinase II, protein kinase C, and
sources of calcium required for the enhancement of release produced by
2-receptor activation. The
Ca2+/calmodulin-dependent kinase II inhibitors
1-[N,O-bis-(5-isoquionolinesulfonyl)]-N-methyl-L-tyrosyl-4-phenylpiperazine and
N-[2-[[[3-(4'-chlorophenyl)-2-propenyl]methylamino]methyl]phenyl]-N-(2-hydroxyethyl)-4'-methoxy-benzenesulfonamide phosphate did not significantly affect the (+)-pentazocine-mediated enhancement of amphetamine-stimulated [3H]DA release.
However, we found that an inhibitor of protein kinase C,
3-[1-[3-(dimethylamino)propyl]-1H-indol-3-yl)-1H-pyrrole-2,5-dione, blocks the (+)-pentazocine-mediated enhancement in rat striatal slices.
The protein kinase C activator phorbol 12-myristate 13-acetate, but not
the inactive isophorbol
4
,9
,12
,13
,20-pentahydroxytiglia-1,6-dien-3-one, enhanced the amphetamine-stimulated [3H]DA release
comparable to the enhancement seen by (+)-pentazocine alone.
Additionally, the L-type voltage-dependent calcium channel inhibitor
nitrendipine or prior treatment with thapsigargin, but not the
N-type voltage-dependent calcium channel
-conotoxin MVIIA, attenuated the (+)-pentazocine-mediated enhancement. Together, these
data suggest that activation of
2-receptors results in the regulation of DAT activity via a calcium- and protein kinase C-dependent signaling mechanism.
This article has been cited by other articles:
![]() |
E. Aydar, C. P. Palmer, and M. B. A. Djamgoz Sigma Receptors and Cancer: Possible Involvement of Ion Channels Cancer Res., August 1, 2004; 64(15): 5029 - 5035. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Kahlig, J. A. Javitch, and A. Galli Amphetamine Regulation of Dopamine Transport: COMBINED MEASUREMENTS OF TRANSPORTER CURRENTS AND TRANSPORTER IMAGING SUPPORT THE ENDOCYTOSIS OF AN ACTIVE CARRIER J. Biol. Chem., March 5, 2004; 279(10): 8966 - 8975. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Nuwayhid and L. L. Werling Steroids Modulate N-Methyl-D-aspartate-Stimulated [3H]Dopamine Release from Rat Striatum via {sigma} Receptors J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 934 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Nuwayhid and L. L. Werling sigma 1 Receptor Agonist-Mediated Regulation of N-Methyl-D-aspartate-Stimulated [3H]Dopamine Release Is Dependent upon Protein Kinase C J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 364 - 369. [Abstract] [Full Text] [PDF] |
||||